Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer

Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer

US Patent 11426453 · Granted Aug 30, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant Mycobacterium as an immunotherapeutic agent for the treatment of can2020
Recombinant Mycobacterium as a vaccine2018
Recombinant mycobacterium as a vaccine2016
Recombinant mycobacterium as vaccine for use in humans2015
Combination of a bacterial cell and a biologically active agent2015
Determination of the efficacy of an anti-mycobacterial vaccination2014
Tuberculosis vaccine with improved efficacy2013
Tuberculosis vaccine with improved efficacy2011